These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 821572)

  • 21. Calcium and phosphorus metabolism in chronic uremia.
    Fiaschi E; Mioni G; Maschio G; D'Angelo A; Ossi E
    Nephron; 1975; 14(2):163-80. PubMed ID: 1093055
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preliminary study of the treatment of nephrolithiasis (calcium stones) with diphosphonate.
    Oata M; Pak CY
    Metabolism; 1974 Dec; 23(12):1167-73. PubMed ID: 4372511
    [No Abstract]   [Full Text] [Related]  

  • 23. The effect of ethane-1-hydroxy-1,1-diphosphonate (EHDP) on calcium oxalate crystalluria in recurrent renal stoneformers.
    Robertson WG; Peacock M; Marshall RW; Knowles F
    Clin Sci Mol Med; 1974 Jul; 47(1):13-22. PubMed ID: 4277691
    [No Abstract]   [Full Text] [Related]  

  • 24. Experimental parturient hypocalcemia in cows following prepartal chemical inhibition of bone resportion.
    Yarrington JT; Capen CC; Black HE; Re R; Potts JT; Geho WB
    Am J Pathol; 1976 Jun; 83(3):569-88. PubMed ID: 180813
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of disodium ethane-1-hydroxy-1,1-diphosphonate (EHDP) on a rabbit model of athero-arteriosclerosis.
    Rosenblum IY; Flora L; Eisenstein R
    Atherosclerosis; 1975; 22(3):411-24. PubMed ID: 812508
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Melorheostosis in adults. Apropos of 2 cases, 1 of them treated with diphosphonate (EHDP)].
    Bied JC; Malsh C; Meunier P
    Rev Rhum Mal Osteoartic; 1976 Mar; 43(3):193-9. PubMed ID: 817388
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The treatment of Paget's bone disease with sodium ethidronate.
    Fromm GA; Schajowicz F; Casco C; Ghiringhelli G; Mautalen CA
    Am J Med Sci; 1979; 277(1):29-37. PubMed ID: 106728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Influence of disodium etidronate (EHDP) on plasma and urinary levels of sodium and potassium in humans].
    Gennari C; Orlandini GA; Nuti R; Francini G
    Boll Soc Ital Biol Sper; 1975 Jul; 51(14):873-7. PubMed ID: 814911
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of diphosphonate on crystallization of calcium oxalate in vitro.
    Pak CY; Ohata M; Holt K
    Kidney Int; 1975 Mar; 7(3):154-60. PubMed ID: 235665
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment of Paget's disease of bone with ethane-1 hydroxy-1, 1 diphosphonate at low dosage (author's transl)].
    Alexandre C; Chapuy MC; Bressot C; Vignon E; Arlot M; Mathieu L; Edouard C; Johnston CC; Meunier PJ
    Nouv Presse Med; 1980 Nov; 9(45):3429-33. PubMed ID: 6777752
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ethane-1-hydroxy-1, 1-diphosphonate (EHDP). Effects on growth and modeling of the rat tibia.
    Miller SC; Jee WS
    Calcif Tissue Res; 1975 Sep; 18(3):215-31. PubMed ID: 810231
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence for the promotion of bone mineralization by 1alpha,25-dihydroxycholecalciferol in the rat unrelated to the correction of deficiencies in serum calcium and phosphorus.
    Boris A; Hurley JF; Trmal T; Mallon JP; Matuszewski DS
    J Nutr; 1978 Dec; 108(12):1899-906. PubMed ID: 102741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Focal osteomalacia due to low-dose diphosphonate therapy in Paget's disease.
    Boyce BF; Smith L; Fogelman I; Johnston E; Ralston S; Boyle IT
    Lancet; 1984 Apr; 1(8381):821-4. PubMed ID: 6143140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Effects of etidronate disodium (EHDP) on urogenital malignancies with bone metastasis: a multicentered collaborative evaluation].
    Kawamura J; Tochigi H; Yanagawa M; Yoshida O; Hida S; Mori O; Suzuki N; Saito K; Komatsu Y; Hatayama T
    Hinyokika Kiyo; 1988 Mar; 34(3):528-37. PubMed ID: 3133934
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Myositis ossificans progressiva treated with diphosphonate].
    Glenting P
    Ugeskr Laeger; 1976 Sep; 138(39):2362-6. PubMed ID: 823676
    [No Abstract]   [Full Text] [Related]  

  • 36. Prevention of ectopic bone formation by local application of ethane-1-hydroxy-1,1-diphosphonate (EHDP): an experimental study in rabbits.
    Ahrengart L; Lindgren U
    J Orthop Res; 1986; 4(1):18-26. PubMed ID: 3081698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Focal mineralization defect during disodium etidronate treatment of calcinosis.
    Weinstein RS
    Calcif Tissue Int; 1982 May; 34(3):224-8. PubMed ID: 6809282
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Paget's disease of bone. Experience with a diphosphonate (disodium etidronate) in treatment.
    Smith R; Russell RG; Bishop MC; Woods CG; Bishop M
    Q J Med; 1973 Apr; 42(166):235-56. PubMed ID: 4206518
    [No Abstract]   [Full Text] [Related]  

  • 39. Therapeutic effects of 25-hydroxycholecalciferol and sodium etidronate on renal osteodystrophy.
    Zucchelli P; Catizone L; Casanova S; Fabbri L; Fusaroli M
    Miner Electrolyte Metab; 1982 Feb; 7(2):86-96. PubMed ID: 6820473
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of ethane-1-hydroxy-1,1-diphosphonate on ectopic bone formation induced by murine osteosarcoma-derived bone-inducing substance.
    Nakahara H; Yoshikawa H; Takaoka K; Ono K
    Bone; 1986; 7(3):229-33. PubMed ID: 3094564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.